Josh Krevitt > Gibson, Dunn & Crutcher LLP > New York, United States > Lawyer Profile
Gibson, Dunn & Crutcher LLP Offices
![Gibson, Dunn & Crutcher LLP company logo](https://www.legal500.com/wp-content/uploads/sites/13/2024/05/GD-Wordmark-Blue-RGB_jpg-300x83.jpg?v=1716300218)
200 PARK AVENUE
NEW YORK, NY 10166-0193
NEW YORK
United States
- Firm Profile
- Go to...
Josh Krevitt
![Josh Krevitt photo](https://www.legal500.com/wp-content/uploads/sites/13/2021/07/jkrevitt-e1717514934804-300x283.jpg)
Work Department
Intellectual Property.
Position
Josh Krevitt is widely recognized as one of the leading IP trial lawyers and litigators in the country. A partner in the New York and Palo Alto offices, Josh is Co-Chair of Gibson Dunn’s Intellectual Property Practice—one of the premier IP practices in the country—and is a member of Gibson Dunn’s Executive Committee. Josh has successfully litigated complex, high-stakes patent cases in courts and in the ITC, with a long and consistent track-record winning complex IP cases at trial, representing plaintiffs and defendants, in jury trials and bench trials. He served as lead counsel for leading technology companies in important and challenging patent cases, including AT&T, T-Mobile, Dell, EMC, Fitbit, Novo Nordisk, Sharp, Merck, RealNetworks, Amazon.com, Viacom, Cablevision, and Shazam.
Lawyer Rankings
United States > Intellectual property > Patents: litigation (full coverage)
(Leading lawyers)The intellectual property practice at Gibson, Dunn & Crutcher LLP features a group of seasoned litigators that acts for clients such as FitBit, Novartis, Dell and SoundCloud in a wide variety of patent infringement cases. The group’s technical expertise is deep and covers a wide range of industry sectors, including chemistry, biotech, software, and telecoms. In New York, Kate Dominguez is highly experienced in tech and life sciences patent disputes at both trial and appeal levels, IP trial lawyer Josh Krevitt focuses on patent and trade secret litigation for major tech companies, and Jane Love is a trusted litigator for pharma and biotech clients. Ernest Hsin in San Francisco specializes in high-tech and life sciences litigation, and Wayne Barsky in Los Angeles has extensive experience in high-profile matters concerning the pharma sector. The group also includes New York-based IP and tech expert Benjamin Hershkowitz as well as trial lawyer Brian Buroker in Washington DC.
Lawyer Rankings
- Leading lawyers United States > Intellectual property > Patents: litigation (full coverage)
- Patents: litigation (full coverage) United States > Intellectual property
Top Tier Firm Rankings
- Antitrust > Cartel
- Antitrust > Civil litigation/class actions: defense
- Government > Government relations
- Energy > Energy transactions: oil and gas
- Environment > Environment: litigation
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Labor and employment > Labor and employment disputes (including collective actions)
- Real estate > Land use/zoning
- Media, technology and telecoms > Media and entertainment: litigation
- Transport > Aviation and air travel: finance
- Media, technology and telecoms > Outsourcing
- Transport > Rail and road: litigation and regulation
- Real estate > Real estate
- Real estate > Real estate finance
- Dispute resolution > Securities litigation: defense
Firm Rankings
- Insurance > Advice to insurers
- Finance > Capital markets: debt offerings
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Energy > Energy transactions: electric power
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Media, technology and telecoms > Media and entertainment: transactional
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Finance > Project finance
- Energy > Renewable/alternative power
- Finance > Restructuring (including bankruptcy): corporate
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: contentious
- Tax > US taxes: non-contentious
- Finance > Capital markets: high-yield debt offerings
- International trade > Customs, export controls and economic sanctions
- Energy > Energy litigation: oil and gas
- Energy > Energy regulation: electric power
- Dispute resolution > Financial services litigation
- Healthcare > Health insurers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Industry focus > Sport
- Media, technology and telecoms > Technology transactions
- Finance > Capital markets: equity offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy litigation: electric power
- Government > Government contracts
- Dispute resolution > International arbitration
- Healthcare > Life sciences
- Finance > Structured finance: derivatives and structured products
- M&A/corporate and commercial > Venture capital and emerging companies
- Finance > Financial services regulation
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Transport > Aviation and air travel: finance